Global GLP-1 for Weight Loss market size is predicted to grow from US$ 4713 million in 2025 to US$ 14990 million in 2031; it is expected to grow at a CAGR of 21.3% from 2025 to 2031.

Global GLP-1 for Weight Loss Market Size, Share and Analysis

The global GLP-1 for Weight Loss market size is predicted to grow from US$ 4713 million in 2025 to US$ 14990 million in 2031; it is expected to grow at a CAGR of 21.3% from 2025 to 2031. GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone in the body that plays a role in glucose homeostasis and appetite regulation. In the context of weight loss, GLP-1 has gained attention due to its potential to influence body weight. GLP-1-based medications, such as GLP-1 receptor agonists, are a class of drugs used primarily for the treatment of type 2 diabetes. However, they have also been found to have beneficial effects on body weight. These drugs mimic the action of GLP-1 in the body, leading to increased insulin secretion, decreased glucagon release, slowed gastric emptying, and a sense of fullness. These effects collectively contribute to improved blood sugar control and a reduction in appetite and food intake. Expanding Indications: GLP-1 receptor agonists were primarily developed for the treatment of type 2 diabetes. However, there was growing interest in their potential application for weight management in individuals without diabetes. Some GLP-1 medications received regulatory approval for weight loss. New Drug Development: Pharmaceutical companies were investing in the research and development of new GLP-1 receptor agonists with enhanced properties, including improved efficacy, longer duration of action, and better tolerability. These developments aimed to address various patient needs and preferences. Combination Therapies: Researchers were exploring the use of GLP-1 medications in combination with other weight loss therapies, such as anti-obesity medications or lifestyle interventions. Combining different approaches could provide synergistic effects in promoting weight loss. Increased Patient Awareness: As more research findings became available and regulatory approvals were granted for weight management, there was an increased awareness among healthcare professionals and patients regarding the potential benefits of GLP-1 receptor agonists for weight loss. Market Competition: With the emergence of new medications and indications, the market for GLP-1-based therapies for weight loss was becoming more competitive. This competition could drive innovation and potentially lead to more accessible and diverse treatment options. Infinity Market Research newest research report, the GLP-1 for Weight Loss Industry Forecast looks at past sales and reviews total world GLP-1 for Weight Loss sales in 2024, providing a comprehensive analysis by region and market sector of projected GLP-1 for Weight Loss sales for 2025 through 2031. With GLP-1 for Weight Loss sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 for Weight Loss industry. This Insight Report provides a comprehensive analysis of the global GLP-1 for Weight Loss landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 for Weight Loss portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global GLP-1 for Weight Loss market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 for Weight Loss and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 for Weight Loss. This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 for Weight Loss market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Injection &nbsp;&nbsp;&nbsp; Oral Agent Segmentation by Application: &nbsp;&nbsp;&nbsp; Woman &nbsp;&nbsp;&nbsp; Man This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Novo Nordisk &nbsp;&nbsp;&nbsp; AstraZeneca &nbsp;&nbsp;&nbsp; Eli Lily &nbsp;&nbsp;&nbsp; GSK &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; Bristol-Myers Squibb &nbsp;&nbsp;&nbsp; Amylin Key Questions Addressed in this Report What is the 10-year outlook for the global GLP-1 for Weight Loss market? What factors are driving GLP-1 for Weight Loss market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do GLP-1 for Weight Loss market opportunities vary by end market size? How does GLP-1 for Weight Loss break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global GLP-1 for Weight Loss Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for GLP-1 for Weight Loss by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for GLP-1 for Weight Loss by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 GLP-1 for Weight Loss Segment by Type &nbsp;2.2.1 Injection &nbsp;2.2.2 Oral Agent &nbsp;2.3 GLP-1 for Weight Loss Sales by Type &nbsp;2.3.1 Global GLP-1 for Weight Loss Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global GLP-1 for Weight Loss Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global GLP-1 for Weight Loss Sale Price by Type (2020-2025) &nbsp;2.4 GLP-1 for Weight Loss Segment by Application &nbsp;2.4.1 Woman &nbsp;2.4.2 Man &nbsp;2.5 GLP-1 for Weight Loss Sales by Application &nbsp;2.5.1 Global GLP-1 for Weight Loss Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global GLP-1 for Weight Loss Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global GLP-1 for Weight Loss Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global GLP-1 for Weight Loss Breakdown Data by Company &nbsp;3.1.1 Global GLP-1 for Weight Loss Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global GLP-1 for Weight Loss Sales Market Share by Company (2020-2025) &nbsp;3.2 Global GLP-1 for Weight Loss Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global GLP-1 for Weight Loss Revenue by Company (2020-2025) &nbsp;3.2.2 Global GLP-1 for Weight Loss Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global GLP-1 for Weight Loss Sale Price by Company &nbsp;3.4 Key Manufacturers GLP-1 for Weight Loss Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers GLP-1 for Weight Loss Product Location Distribution &nbsp;3.4.2 Players GLP-1 for Weight Loss Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for GLP-1 for Weight Loss by Geographic Region &nbsp;4.1 World Historic GLP-1 for Weight Loss Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global GLP-1 for Weight Loss Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global GLP-1 for Weight Loss Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic GLP-1 for Weight Loss Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global GLP-1 for Weight Loss Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global GLP-1 for Weight Loss Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas GLP-1 for Weight Loss Sales Growth &nbsp;4.4 APAC GLP-1 for Weight Loss Sales Growth &nbsp;4.5 Europe GLP-1 for Weight Loss Sales Growth &nbsp;4.6 Middle East & Africa GLP-1 for Weight Loss Sales Growth 5 Americas &nbsp;5.1 Americas GLP-1 for Weight Loss Sales by Country &nbsp;5.1.1 Americas GLP-1 for Weight Loss Sales by Country (2020-2025) &nbsp;5.1.2 Americas GLP-1 for Weight Loss Revenue by Country (2020-2025) &nbsp;5.2 Americas GLP-1 for Weight Loss Sales by Type (2020-2025) &nbsp;5.3 Americas GLP-1 for Weight Loss Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC GLP-1 for Weight Loss Sales by Region &nbsp;6.1.1 APAC GLP-1 for Weight Loss Sales by Region (2020-2025) &nbsp;6.1.2 APAC GLP-1 for Weight Loss Revenue by Region (2020-2025) &nbsp;6.2 APAC GLP-1 for Weight Loss Sales by Type (2020-2025) &nbsp;6.3 APAC GLP-1 for Weight Loss Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe GLP-1 for Weight Loss by Country &nbsp;7.1.1 Europe GLP-1 for Weight Loss Sales by Country (2020-2025) &nbsp;7.1.2 Europe GLP-1 for Weight Loss Revenue by Country (2020-2025) &nbsp;7.2 Europe GLP-1 for Weight Loss Sales by Type (2020-2025) &nbsp;7.3 Europe GLP-1 for Weight Loss Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa GLP-1 for Weight Loss by Country &nbsp;8.1.1 Middle East & Africa GLP-1 for Weight Loss Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa GLP-1 for Weight Loss Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa GLP-1 for Weight Loss Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa GLP-1 for Weight Loss Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of GLP-1 for Weight Loss &nbsp;10.3 Manufacturing Process Analysis of GLP-1 for Weight Loss &nbsp;10.4 Industry Chain Structure of GLP-1 for Weight Loss 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 GLP-1 for Weight Loss Distributors &nbsp;11.3 GLP-1 for Weight Loss Customer 12 World Forecast Review for GLP-1 for Weight Loss by Geographic Region &nbsp;12.1 Global GLP-1 for Weight Loss Market Size Forecast by Region &nbsp;12.1.1 Global GLP-1 for Weight Loss Forecast by Region (2026-2031) &nbsp;12.1.2 Global GLP-1 for Weight Loss Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global GLP-1 for Weight Loss Forecast by Type (2026-2031) &nbsp;12.7 Global GLP-1 for Weight Loss Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Novo Nordisk &nbsp;13.1.1 Novo Nordisk Company Information &nbsp;13.1.2 Novo Nordisk GLP-1 for Weight Loss Product Portfolios and Specifications &nbsp;13.1.3 Novo Nordisk GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Novo Nordisk Main Business Overview &nbsp;13.1.5 Novo Nordisk Latest Developments &nbsp;13.2 AstraZeneca &nbsp;13.2.1 AstraZeneca Company Information &nbsp;13.2.2 AstraZeneca GLP-1 for Weight Loss Product Portfolios and Specifications &nbsp;13.2.3 AstraZeneca GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 AstraZeneca Main Business Overview &nbsp;13.2.5 AstraZeneca Latest Developments &nbsp;13.3 Eli Lily &nbsp;13.3.1 Eli Lily Company Information &nbsp;13.3.2 Eli Lily GLP-1 for Weight Loss Product Portfolios and Specifications &nbsp;13.3.3 Eli Lily GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Eli Lily Main Business Overview &nbsp;13.3.5 Eli Lily Latest Developments &nbsp;13.4 GSK &nbsp;13.4.1 GSK Company Information &nbsp;13.4.2 GSK GLP-1 for Weight Loss Product Portfolios and Specifications &nbsp;13.4.3 GSK GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 GSK Main Business Overview &nbsp;13.4.5 GSK Latest Developments &nbsp;13.5 Sanofi &nbsp;13.5.1 Sanofi Company Information &nbsp;13.5.2 Sanofi GLP-1 for Weight Loss Product Portfolios and Specifications &nbsp;13.5.3 Sanofi GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Sanofi Main Business Overview &nbsp;13.5.5 Sanofi Latest Developments &nbsp;13.6 Bristol-Myers Squibb &nbsp;13.6.1 Bristol-Myers Squibb Company Information &nbsp;13.6.2 Bristol-Myers Squibb GLP-1 for Weight Loss Product Portfolios and Specifications &nbsp;13.6.3 Bristol-Myers Squibb GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Bristol-Myers Squibb Main Business Overview &nbsp;13.6.5 Bristol-Myers Squibb Latest Developments &nbsp;13.7 Amylin &nbsp;13.7.1 Amylin Company Information &nbsp;13.7.2 Amylin GLP-1 for Weight Loss Product Portfolios and Specifications &nbsp;13.7.3 Amylin GLP-1 for Weight Loss Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Amylin Main Business Overview &nbsp;13.7.5 Amylin Latest Developments 14 Research Findings and Conclusion

Report	Global GLP-1 for Weight Loss Market Growth, Trends and Opportunities 2025-31
Selected License	Multi ID: LPI50611

Buyer Information

Order Summary